Continuing Education for the Prevention of Mild Cognitive Impairment and Alzheimer's-type Dementia: a Systematic Review Protocol

Overview

Journal Syst Rev

Publisher Biomed Central

Date 2017 Aug 10

PMID 28789697

Citations 8

Authors

Nina Matyas

Stefanie Auer

Christoph Gisinger

Monika Kil

Filiz Keser Aschenberger

Irma Klerings

Gerald Gartlehner

Affiliations

Soon will be listed here.

Abstract

Background: Because of the enormous social and economic burden of disease, the prevention of mild cognitive impairment and Alzheimer's-type dementia has become a major global public health priority. Studies show that cognitively stimulating activities during middle adulthood might have a protective effect on the brain by boosting the cognitive reserve. The aim of this review is to identify evidence investigating the effects of continuing education for the prevention of mild cognitive impairment and Alzheimer's-type dementia in late life.

Methods: Our approach employs a two-stage design: First, we will conduct a systematic review to assess the preventive effects of continuing education on mild cognitive impairment and Alzheimer's-type dementia. Second, because we expect to find few studies, we will perform a review of systematic reviews on leisure activities that mimic formal continuing education to determine their effects on the prevention of mild cognitive impairment and Alzheimer's-type dementia. We will search electronic databases (e.g., MEDLINE, PsycINFO, EMBASE, CENTRAL, CINAHL, and Scopus) for published studies and gray literature databases (e.g., trial registries) for unpublished studies. Two authors will independently screen abstracts and full-texts using pre-defined eligibility criteria, select studies, extract data, and assess the quality of included studies or reviews. Outcomes of interest include the incidence of mild cognitive impairment or Alzheimer's-type dementia, quality of life, functional capacity, and psychological wellbeing. Intermediate outcomes are cognitive (test) performance, cognitive functioning, and social inclusion. The review team is a multidisciplinary group consisting of methodological experts and dementia, geriatrics, and continuing education researchers.

Discussion: We anticipate that our review will highlight serious gaps in the current evidence. Results will build the basis for further research regarding the relation of continuing education and cognitive decline and dementia.

Systematic Review Registration: PROSPERO CRD42017063944.

Citing Articles

Feasibility of Identifying Factors Related to Alzheimer's Disease and Related Dementia in Real-World Data.

Chen A, Li Q, Huang Y, Li Y, Chuang Y, Hu X medRxiv. 2024; .

PMID: 38405723 PMC: 10889002. DOI: 10.1101/2024.02.10.24302621.

Motor-Cognitive Interventions May Effectively Improve Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial.

Tao M, Liu H, Cheng J, Yu C, Zhao L Behav Sci (Basel). 2023; 13(9).

PMID: 37754015 PMC: 10525591. DOI: 10.3390/bs13090737.

The Janus-like Association between Proton Pump Inhibitors and Dementia.

Papazoglou A, Arshaad M, Henseler C, Daubner J, Broich K, Haenisch B Curr Alzheimer Res. 2021; 18(6):453-469.

PMID: 34587884 PMC: 8778640. DOI: 10.2174/1567205018666210929144740.

Potential application of human neural crest-derived nasal turbinate stem cells for the treatment of neuropathology and impaired cognition in models of Alzheimer's disease.

Lim J, Park S, Park S, Jeon J, Jung H, Yon J Stem Cell Res Ther. 2021; 12(1):402.

PMID: 34256823 PMC: 8278635. DOI: 10.1186/s13287-021-02489-1.

The Efficacy of Cognitive Training for Elderly Chinese Individuals with Mild Cognitive Impairment.

Peng Z, Jiang H, Wang X, Huang K, Zuo Y, Wu X Biomed Res Int. 2019; 2019:4347281.

PMID: 31886216 PMC: 6907055. DOI: 10.1155/2019/4347281.

References

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P . Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988; 23(2):138-44. DOI: 10.1002/ana.410230206. View

McGowan J, Sampson M, Salzwedel D, Cogo E, Foerster V, Lefebvre C . PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016; 75:40-6. DOI: 10.1016/j.jclinepi.2016.01.021. View

Wilson R, Scherr P, Schneider J, Tang Y, Bennett D . Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007; 69(20):1911-20. DOI: 10.1212/01.wnl.0000271087.67782.cb. View

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

Beydoun M, Beydoun H, Gamaldo A, Teel A, Zonderman A, Wang Y . Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health. 2014; 14:643. PMC: 4099157. DOI: 10.1186/1471-2458-14-643. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View

10.

Bosma H, van Boxtel M, Ponds R, Jelicic M, Houx P, Metsemakers J . Engaged lifestyle and cognitive function in middle and old-aged, non-demented persons: a reciprocal association?. Z Gerontol Geriatr. 2002; 35(6):575-81. DOI: 10.1007/s00391-002-0080-y. View

11.

. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016; 12(4):459-509. DOI: 10.1016/j.jalz.2016.03.001. View

12.

Petersen R . Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256(3):183-94. DOI: 10.1111/j.1365-2796.2004.01388.x. View

13.

Scarmeas N, Stern Y . Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep. 2004; 4(5):374-80. PMC: 3026565. DOI: 10.1007/s11910-004-0084-7. View

14.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

15.

Tucker A, Stern Y . Cognitive reserve in aging. Curr Alzheimer Res. 2011; 8(4):354-60. PMC: 3135666. DOI: 10.2174/156720511795745320. View

16.

Wilson R, Mendes de Leon C, Barnes L, Schneider J, Bienias J, Evans D . Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002; 287(6):742-8. DOI: 10.1001/jama.287.6.742. View

17.

Wilson R, Boyle P, Yu L, Barnes L, Schneider J, Bennett D . Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013; 81(4):314-21. PMC: 3772831. DOI: 10.1212/WNL.0b013e31829c5e8a. View

18.

Sharp E, Gatz M . Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord. 2011; 25(4):289-304. PMC: 3193875. DOI: 10.1097/WAD.0b013e318211c83c. View

19.

Hultsch D, Hertzog C, Small B, Dixon R . Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging?. Psychol Aging. 1999; 14(2):245-63. DOI: 10.1037//0882-7974.14.2.245. View

20.

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H . Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016; 15(5):455-532. DOI: 10.1016/S1474-4422(16)00062-4. View